Search alternatives:
mean decrease » a decrease (Expand Search)
teer decrease » greater decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
Showing 201 - 220 results of 33,336 for search '(( 20 mean decrease ) OR ( 5 ((((we decrease) OR (nn decrease))) OR (teer decrease)) ))', query time: 0.65s Refine Results
  1. 201
    Effects of FE and RUD wrist postures on the mean shape signature distance from the template within each quartile.

    Effects of FE and RUD wrist postures on the mean shape signature distance from the template within each quartile. by Drew A. Anderson (14197446)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  2. 202
    Illustration of the predicted mean (n = 10) twist along the carpal tunnel in neutral and with combined FE and RUD postures.

    Illustration of the predicted mean (n = 10) twist along the carpal tunnel in neutral and with combined FE and RUD postures. by Drew A. Anderson (14197446)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  3. 203
    Age-specific infection fatality ratio (IFR) of COVID-19 on a log-scale (mean ± 95% CI).

    Age-specific infection fatality ratio (IFR) of COVID-19 on a log-scale (mean ± 95% CI). by Chloe G. Rickards (14035038)

    Published 2023
    Save to List
    Saved in:
  4. 204
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 205
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 206
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 207
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 208
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 209
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 210
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 211
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 212
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 213
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 214
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 215
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 216
    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.

    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 217
    Procedure related data, LBNP, LBPP and hypoxia.

    Procedure related data, LBNP, LBPP and hypoxia. by Marcus Thudium (6441863)

    Published 2023
    “…Decreasing levels of LBNP were applied in 5-minute steps until subjects reached presyncope. …”
    Save to List
    Saved in:
  18. 218
    Individual biometric data of patients.

    Individual biometric data of patients. by Marcus Thudium (6441863)

    Published 2023
    “…Decreasing levels of LBNP were applied in 5-minute steps until subjects reached presyncope. …”
    Save to List
    Saved in:
  19. 219
    Comparison of the study groups in terms of the mean score of VAS scale, on days 1,7,10, and 14 post-intervention.

    Comparison of the study groups in terms of the mean score of VAS scale, on days 1,7,10, and 14 post-intervention. by Masoumeh Sayahi (17468290)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 220
    Comparison of the study groups in terms of the mean score of REEDA scale, on days 1,7,10 and 14 post-intervention.

    Comparison of the study groups in terms of the mean score of REEDA scale, on days 1,7,10 and 14 post-intervention. by Masoumeh Sayahi (17468290)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: